Cefepime Hydrochloride And Dextrose Injection, Solution
Product Images NDC 0264-3193

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cefepime Hydrochloride And Dextrose (NDC 0264-3193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram 1 (Cefepime For Injection In Duplex 1)

An instructional diagram labeled 'Diagram 1' depicting a medication vial within a holder or packaging. The diagram highlights a 'Side Tab' on the container, which appears to be a part of the mechanism to open or remove the vial from its packaging.*

FDA Label Image

Cefepime For Injection In Duplex 10

Text panel titled 'Drug Chamber' containing instructions to discard the unit if the foil strip is damaged, peel the foil strip only when ready for use, and visually inspect the drug prior to reconstitution. It also advises referring to the package insert for complete directions for reconstitution and administration.*

FDA Label Image

Diagram 2 (Cefepime For Injection In Duplex 2)

An illustrated diagram showing components of a CEFEPIME HYDROCHLORIDE AND DEXTROSE injection solution container. Key parts labeled include the Hanger Tab, Diluent Chamber, Foil Strip, Drug Powder Chamber, and a Set Port with Foil Cover. The diagram indicates how to peel open the foil strip to access the drug powder chamber.*

FDA Label Image

Diagram 3 (Cefepime For Injection In Duplex 3)

An instructional diagram labeled 'Diagram 3' illustrating a hand manipulating a medical device, likely showing the process of breaking or opening a container or vial, associated with intravenous injection preparation.*

FDA Label Image

Diagram 4 (Cefepime For Injection In Duplex 4)

An instructional diagram labeled 'Diagram 4' showing hands holding a medical solution bag, with an arrow indicating a step involving the bag's port or closure mechanism, likely related to preparing or administering the intravenous injection solution.*

FDA Label Image

Diagram 5 (Cefepime For Injection In Duplex 5)

An instructional diagram showing a solution injection bag with a set port and foil cover labeled. The image illustrates how to access the set port by removing the foil cover, typically for intravenous administration.*

FDA Label Image

Chemical Structure (Cefepime For Injection In Duplex 6)

Chemical structure of Cefepime Hydrochloride, showing its detailed molecular composition including functional groups and stereochemistry.*

FDA Label Image

3193-11 Container Label (Cefepime For Injection In Duplex 7)

Chemical structure of dextrose, a component of the CEFEPIME HYDROCHLORIDE AND DEXTROSE injection solution.*

FDA Label Image

3195-11 Container Label (Cefepime For Injection In Duplex 8)

Label for Cefepime for Injection USP and Dextrose Injection USP, 1 g/50 mL intravenous injection solution in a duplex container. Manufactured by B. Braun Medical Inc., the label includes usage instructions, storage conditions, and quality warnings, along with the NDC 0264-3193-11 and a barcode. The product is sterile, single-dose, hyperosmotic, and not made with natural rubber latex, PVC, or DEHP.*

FDA Label Image

Display Panel Drug Barrier Strip (Cefepime For Injection In Duplex 9)

Label for Cefepime for Injection USP and Dextrose Injection USP, 2 g/50 mL solution in a duplex container. The product is an intravenous single-dose sterile solution containing 2 g of cefepime hydrochloride and hydrous dextrose. It is marketed by B. Braun Medical Inc., Bethlehem, PA. The label includes storage, reconstitution instructions, and barcode with NDC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.